vorapaxar   Click here for help

GtoPdb Ligand ID: 4047

Synonyms: SCH 530348 | SCH-530348 | SCH530348 | Zontivity®
Approved drug PDB Ligand
vorapaxar is an approved drug (FDA (2014))
Compound class: Synthetic organic
Comment: Vorapaxar is an orally active thrombin receptor (PAR1) antagonist based on the natural product himbacine [1], that is used as an anti-thrombosis drug.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: vorapaxar

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 77.52
Molecular weight 492.24
XLogP 5.52
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CCOC(=O)NC1CCC2C(C1)CC1C(C2C=Cc2ccc(cn2)c2cccc(c2)F)C(OC1=O)C
Isomeric SMILES CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](OC1=O)C
InChI InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1
1. Chackalamannil S, Wang Y, Greenlee WJ, Hu Z, Xia Y, Ahn HS, Boykow G, Hsieh Y, Palamanda J, Agans-Fantuzzi J et al.. (2008)
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.
J Med Chem, 51 (11): 3061-4. [PMID:18447380]
2. Sriram K, Insel PA. (2020)
Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?.
Br J Pharmacol, 177 (21): 4971-4974. [PMID:32639031]
3. Ueno M, Ferreiro JL, Angiolillo DJ. (2010)
Mechanism of action and clinical development of platelet thrombin receptor antagonists.
Expert Rev Cardiovasc Ther, 8 (8): 1191-200. [PMID:20670195]